DCM
ZLAB icon

Diag Capital Management’s Zai Lab ZLAB Stock Holding History

Diag Capital Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.79M Buy
+120,092
New +$2.23M 3.19% 14

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Diag Capital Management's ZLAB Position: Q4 2018 in Review

Diag Capital Management opened a new position in Zai Lab (ZLAB) in Q4 2018: 120,092 shares worth $2.79M. The stake represents 3.19% of the portfolio and ranks #14 among its holdings.

61 funds tracked by Wall St. Rank hold ZLAB as of Q4 2018.

  • Diag Capital Management held 120,092 shares of Zai Lab worth $2.79M as of Q4 2018.
  • Zai Lab was a new Diag Capital Management position in Q4 2018.
  • Zai Lab made up 3.19% of Diag Capital Management's portfolio in Q4 2018, its #14 holding.
  • 61 funds tracked by Wall St. Rank held Zai Lab as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.